ASHLEY AHRING: Open Payments
NPI 1447264395 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,243 in 64 payments from 18 companies in 2025. Trend: 2023 $1,789 · 2024 $1,867 · 2025 $1,243
Food & beverage: $1,144Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $267 |
| PFIZER INC. | 8 | $164 |
| Janssen Biotech, Inc. | 4 | $151 |
| Amgen Inc. | 6 | $144 |
| UCB, Inc. | 5 | $95 |
| E.R. Squibb & Sons, L.L.C. | 4 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Biocon Biologics Inc | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
Products named: XELJANZ, TREMFYA, SKYRIZI, RINVOQ, Bimzelx, ORENCIA, COSENTYX, BENLYSTA.
Industry payments across KS — which companies pay providers there.
